Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified January 2013 by University Hospital, Clermont-Ferrand
H. Lundbeck A/S, TEVA
CHU Purpan (Toulouse)
Hôpital Haut-Levêque (Pessac)
Centre Hospitalier de la Côte Basque
Centre Hospitalier Universitaire de Poitiers (Poitiers)
CHU de Rennes (Rennes)
University Hospital, Lille
CHU Dupuytren (Limoges)
University Hospital, Caen
Hôpital Caremeau (NIMES)
Centre Hospitalier Pays D'Aix
Hôpital de la Timone (MARSEILLE)
University Hospital, Rouen
Centre Hospitalier Universitaire, Amiens
Centre Hospitalier Universitaire de Saint Etienne
Fondation Rothschild Paris
Information provided by (Responsible Party):
University Hospital, Clermont-Ferrand Identifier:
First received: January 8, 2013
Last updated: January 9, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)